Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from ASKA Pharmaceutical Holdings Co., Ltd. ( (JP:4886) ) is now available.
ASKA Pharmaceutical Holdings Co., Ltd. reported record-high sales for the second quarter of FY2025, driven by steady domestic performance and contributions from its overseas business. Despite increased R&D and sales promotion expenses impacting operating profit, the company revised its financial forecast upward, expecting a 10.7% increase in net sales and a 12.5% rise in operating profit for the fiscal year.
The most recent analyst rating on (JP:4886) stock is a Hold with a Yen2305.00 price target. To see the full list of analyst forecasts on ASKA Pharmaceutical Holdings Co., Ltd. stock, see the JP:4886 Stock Forecast page.
More about ASKA Pharmaceutical Holdings Co., Ltd.
ASKA Pharmaceutical Holdings Co., Ltd. operates in the pharmaceutical industry, focusing on the development and sale of ethical drugs. The company has a strong domestic market presence and is expanding its operations overseas.
Average Trading Volume: 75,832
Technical Sentiment Signal: Sell
Current Market Cap: Yen55.73B
Learn more about 4886 stock on TipRanks’ Stock Analysis page.